Primary Sjögren's Syndrome — UCB Proof of Concept Study in Patients With Primary Sjögren's Syndrome
Citation(s)
A Randomized, Double-blind, Placebo-controlled, Proof-of-concept Study to Evaluate the Efficacy of UCB5857 Over 12 Weeks in Subjects With Primary Sjögren's Syndrome